Pointerra signs MoU to commercially licence technology

|

Published 15-JUN-2017 13:12 P.M.

|

3 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.


Click Here to View Latest Articles

Developer of unique 3-D geospatial data technology, Pointerra (ASX:3DP) has entered into a Memorandum of Understanding (MOU) with AAM Pty Ltd (AAM) to commercially licence Pointerra’s 3D geospatial technology.

AAM is a world leader in geospatial technologies, and the company has been modelling the built and natural environment in 3D since 1995. AAM is the largest private holder of geographic information system (GIS) data in Australia, and the group has been at the forefront of aerial 3D data capture for many years, resulting in the compilation of a comprehensive temporal library of 3D data and derivative products.

Consequently, partnering with such a prominent player in the sector is a coup for 3DP as it moves to strengthen its global positioning in the 3D data space. Commenting on this development, the company’s Managing Director, Ian Olson said, “We are delighted to have secured an important data partner in AAM, who is the pre-eminent geospatial and GIS business in our region”.

It should be noted that this partnership is in the early stage of development and investors should seek professional financial advice if considering this stock for their portfolio.

Olson highlighted the fact that the MOU and subsequent licence and partnership agreement represent another milestone in 3DP’s vision to lead the global market for 3D data. Of significance is the fact that both companies are working on similar software licence, partnership and data licensing relationships with other leading regional and global
enterprise partners and data owners.

how pointerra's technology works

AAM provides state of the art access to its valuable data through various channels, including its GEOCIRRUS cloud-based GIS solution via a Data as a Service (DaaS) model and the GEOCIRRUS Discovery Portal, the AAM shopfront for data/content.

As part of expanding and improving its GEOCIRRUS strategy, AAM has agreed to licence, under a commercial agreement, 3DP’s unique 3D geospatial technology. Both parties are currently working to integrate 3DP’s technology into GEOCIRRUS, enabling AAM to more effectively sell access to its 3D data library.

Under the MOU, 3DP will also be licenced by AAM to sell access to AAM’s 3D data (and derivative products) through its own 3D data marketplace.

Building a recurring revenue stream provides investor confidence

While the full commercial terms of the relationship will be documented in a formal technology licence and partnership agreement, to be concluded by no later than July 2017, Olson pointed to some of the key components of the arrangement.

AAM will pay 3DP a one-off licence fee for the use of 3DP’s technology in GEOCIRRUS, as well as paying a royalty based on data usage through the GEOCIRRUS Discovery Portal. This will provide important recurring revenue for 3DP and provide investors with the comfort of income predictability.

3DP will pay AAM a royalty based on data sales made through its data marketplace.

Monetising 3DP’s technology through a mix of licence fees and royalty payments

In highlighting the key goals surrounding such partnerships, 3DP’s Managing Director, Ian Olson said, “The common theme of these relationships and agreements is to monetise 3DP’s technology through a mix of licence fees and royalty payments while adding to 3DP’s world-first 3D data library as part of our global 3D data marketplace”.

Explaining the significance of 3DP’s technology in terms of strengthening AAM’s business, Chief Executive, Mark Freeburn, said, “When we launched GEOCIRRUS in 2015, AAM was one of the first geospatial organisations in the world to provide a cloud-based delivery solution and DaaS marketplace, and by partnering with 3DP we have added a step-change in dimension and scale by being able to visualise and promote access for our customers to our considerable library of 3D datasets”.

Freeburn also went on to emphasise that 3DP’s technology would help AAM in leveraging its data to grow the GEOCIRRUS market place, making the agreement a win-win for both companies.



General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.

 

Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free

X